Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 26

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 3
Chunk 26
---
.

In addition, despite the implementation
of security measures, its internal computer systems, and those of its provider clinics, specialty pharmacies or other downstream vendors,
are potentially vulnerable to damage from malicious intrusion, malware, computer viruses, unauthorized access, natural disasters, terrorism,
war and telecommunication and electrical failures. While NewGenIvf is not aware that it has experienced any such system failure, accident
or security breach to date, if such an event were to occur and cause interruptions in its operations, it could result in a material disruption
to its ability to operate and deliver its solutions. In addition, to the extent that any disruption or security breach were to result
in a loss or inappropriate disclosure of confidential information, NewGenIvf could incur liability. See “ - Risks Related
to Government Regulation - NewGenIvf operates in a highly regulated industry and must comply with a significant number
of complex and evolving requirements. Any lack of requisite approvals, licenses, or permits applicable to NewGenIvf’s business may
have a material and adverse impact on NewGenIvf’s business, financial condition, and results of operations - Data
Protection and Breaches.”

Risks Related to NewGenIvf’s Relationships with Third Parties

NewGenIvf’s business depends on its
ability to maintain its network of high-quality fertility specialists and other healthcare providers. If NewGenIvf is unable to do so,
its future growth would be limited and its business, financial condition and results of operations would be harmed.

NewGenIvf’s performance
and success is dependent upon its continued ability to maintain a credentialed network of high-quality fertility specialists, including
its senior management team, other key employees, as well as research and development and operation maintenance personnel, many of whom
are difficult to replace. Fertility specialists could refuse to contract, demand higher payments or take other actions that could result
in higher medical costs, less attractive service for its clients or difficulty meeting regulatory or accreditation requirements. Identifying
high-quality fertility specialists, credentialing and negotiating contracts with them and evaluating, monitoring and maintaining its network,
requires significant time and resources. Competition in the healthcare industry for qualified employees is intense. NewGenIvf may need
to offer higher compensation and other benefits in order to attract and retain key personnel in the future, which could increase NewGenIvf’s
compensation expenses, including stock-based compensation. NewGenIvf’s continued ability to compete effectively depends on NewGenIvf’s
ability to attract new employees